Special Analysis: Addressing Key Concerns Around the FDA’s Final LDTs Rule
Experts answer key questions related to laboratory-developed test regulation during G2 Intelligence webinar.
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
Experts answer key questions related to laboratory-developed test regulation during G2 Intelligence webinar.
From - G2 Compliance Advisor
A Florida clinic has settled a False Claims Act case relating to drug testing for $7.4 million. Quantitative drug tests that…
From - G2 Compliance Advisor
When asked why he robbed banks, the notorious outlaw Willie Sutton famously replied: "Because that's where they keep…
From - G2 Compliance Advisor
When the Centers for Medicare & Medicaid Services (CMS) announced in mid-June the final rules governing the Protecting the…
From - G2 Compliance Advisor
Theranos has announced that it is appealing the Centers for Medicare & Medicaid's threatened sanctions. The announcement also indicated that…
From - G2 Compliance Advisor
The Office of Inspector General's Compliance Program Guidance for Clinical Laboratories includes among its seven elements for a comprehensive compliance program…
From - G2 Compliance Advisor
While labs may draft a comprehensive compliance plan and policies and procedures, those policies, procedures and plan can be a liability if…